Correction of Termination of Single Sales/Supply Contract and Continuous Disclosure Reservation
-
Disclosure of contract termination and disclosure reservation correction (correction date: 2026-04-30)
-
Out of original contract amount of 488,800,000 KRW, actual performance amount is only 143,000,000 KRW (29.3%)
-
Continuous disclosure reservation due to counterparty's request (protection of trade secrets)
-
Contract end date: 2026-04-30 (expiration and termination)
-
Only summary information provided per KOSDAQ disclosure regulations
KOSDAQ Filing Information
-
Filing: [Correction of Description] Conclusion of Single Sale and Supply Contract
-
Company: Prestige Biologics (334970)
-
Submission: Prestige Biologics Co., Ltd.
-
Receipt: 04-30-2026
-
Under KRX KOSDAQ Market Division